{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Salvia", "clinical study", "cognitive dysfunction", "ethnopharmacology", "memory enhancement", "sage"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37259321", "DateRevised": {"Year": "2023", "Month": "06", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "23"}], "Language": ["eng"], "ELocationID": ["171", "10.3390/ph16020171"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Jan", "Day": "23"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "A Focused Review on Cognitive Improvement by the Genus <i>Salvia</i> L. (Sage)-From Ethnopharmacology to Clinical Evidence.", "Abstract": {"AbstractText": ["Ethnopharmacology has been an important starting point in medical and pharmaceutical sciences for discovering drug candidates from natural sources. In this regard, the genus <i>Salvia</i> L., commonly known as sage, is one of the best-known medicinal and aromatic plants of the Lamiaceae family; it has been recorded as being used for memory enhancement in European folk medicine. Despite the various uses of sage in folk medicines, the records that have pointed out sage's memory-enhancing properties have paved the way for the aforementioned effect to be proven on scientific grounds. There are many preclinical studies and excellent reviews referring to the favorable effect of different species of sage against the cognitive dysfunction that is related to Alzheimer's disease (AD). Hence, the current review discusses clinical studies that provide evidence for the effect of <i>Salvia</i> species on cognitive dysfunction. Clinical studies have shown that some <i>Salvia</i> species, i.e., hydroalcoholic extracts and essential oils of <i>S. officinalis</i> L. and <i>S. lavandulaefolia</i> leaves in particular, have been the most prominently effective species in patients with mild to moderate AD, and these species have shown positive effects on the memory of young and healthy people. However, the numbers of subjects in the studies were small, and standardized extracts were not used for the most part. Our review points out to the need for longer-term clinical studies with higher numbers of subjects being administered standardized sage preparations."]}, "AuthorList": [{"Identifier": ["0000-0002-2193-8386"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Analytical Chemistry, Faculty of Pharmacy, Dicle University, Diyarbakir 21200, T\u00fcrkiye."}], "LastName": "Ertas", "ForeName": "Abdulselam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Dicle University, Diyarbakir 21200, T\u00fcrkiye."}], "LastName": "Yigitkan", "ForeName": "Serkan", "Initials": "S"}, {"Identifier": ["0000-0002-7379-5436"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara 06330, T\u00fcrkiye."}], "LastName": "Orhan", "ForeName": "Ilkay Erdogan", "Initials": "IE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Machado S., Cunha M., Minc D., Portella C.E., Velasques B., Basile L.F., Cagy M., Piedade R., Ribeiro P. Alzheimer\u2019s disease and implicit memory. Arq. Neuropsiquiatr. 2009;67:334\u2013342. doi: 10.1590/S0004-282X2009000200034.", "ArticleIdList": ["10.1590/S0004-282X2009000200034", "19547837"]}, {"Citation": "Jahn H. Memory loss in Alzheimer\u2019s disease. Dialogues Clin. Neurosci. 2013;15:445\u2013454. doi: 10.31887/DCNS.2013.15.4/hjahn.", "ArticleIdList": ["10.31887/DCNS.2013.15.4/hjahn", "PMC3898682", "24459411"]}, {"Citation": "Zokaei N., Husain M. Processes of Visuospatial Attention and Working Memory. Volume 41. Springer; Cham, Switzerland: 2019. Working memory in Alzheimer\u2019s disease and Parkinson\u2019s disease; pp. 325\u2013344.", "ArticleIdList": ["10.1007/7854_2019_103", "31347008"]}, {"Citation": "Park J.H., Lee S.A. The fragility of temporal memory in Alzheimer\u2019s disease. J. Alzheimers Dis. 2021;79:1631\u20131646. doi: 10.3233/JAD-200892.", "ArticleIdList": ["10.3233/JAD-200892", "33459713"]}, {"Citation": "Pe\u00f1a-Casanova J., Sanchez-Benavides G., de Sola S., Manero-Borr\u00e1s R.M., Casals-Coll M. Neuropsychology of Alzheimer\u2019s disease. Arch. Med. Res. 2012;43:686\u2013693. doi: 10.1016/j.arcmed.2012.08.015.", "ArticleIdList": ["10.1016/j.arcmed.2012.08.015", "23072720"]}, {"Citation": "Breijyeh Z., Karaman R. Comprehensive review on Alzheimer\u2019s disease: Causes and treatment. Molecules. 2020;25:5789. doi: 10.3390/molecules25245789.", "ArticleIdList": ["10.3390/molecules25245789", "PMC7764106", "33302541"]}, {"Citation": "Kang S., Kim J., Chang K.A. Spatial memory deficiency early in 6xTg Alzheimer\u2019s disease mouse model. Sci. Rep. 2021;11:1334. doi: 10.1038/s41598-020-79344-5.", "ArticleIdList": ["10.1038/s41598-020-79344-5", "PMC7809274", "33446720"]}, {"Citation": "Davies P. Challenging the cholinergic hypothesis in Alzheimer disease. JAMA. 1999;281:1433\u20131434. doi: 10.1001/jama.281.15.1433.", "ArticleIdList": ["10.1001/jama.281.15.1433", "10217061"]}, {"Citation": "Lane R.M., Kivipelto M., Greig N.H. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin. Neuropharmacol. 2004;27:141\u2013149. doi: 10.1097/00002826-200405000-00011.", "ArticleIdList": ["10.1097/00002826-200405000-00011", "15190239"]}, {"Citation": "Sivaprakasam K. Towards a unifying hypothesis of Alzheimer\u2019s disease: Cholinergic system linked to plaques, tangles and neuroinflammation. Curr. Med. Chem. 2006;13:2179\u20132188. doi: 10.2174/092986706777935203.", "ArticleIdList": ["10.2174/092986706777935203", "16918347"]}, {"Citation": "Niquet J., Lumley L., Baldwin R., Rossetti F., Suchomelova L., Naylor D., Estrada I.B.F., Schultz M., Furtado M.D.A., Wasterlain C.G. Rational polytherapy in the treatment of cholinergic seizures. Neurobiol. Dis. 2020;133:104537. doi: 10.1016/j.nbd.2019.104537.", "ArticleIdList": ["10.1016/j.nbd.2019.104537", "31454548"]}, {"Citation": "Chen Z.R., Huang J.B., Yang S.L., Hong F.F. Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules. 2022;27:1816. doi: 10.3390/molecules27061816.", "ArticleIdList": ["10.3390/molecules27061816", "PMC8949236", "35335180"]}, {"Citation": "Ha Z.Y., Mathew S., Yeong K.Y. Butyrylcholinesterase: A multifaceted pharmacological target and tool. Curr. Protein Pept. Sci. 2020;21:99\u2013109. doi: 10.2174/1389203720666191107094949.", "ArticleIdList": ["10.2174/1389203720666191107094949", "31702488"]}, {"Citation": "Guillozet A.L., Smiley J.F., Mash D.C., Mesulam M.M. Butyrylcholinesterase in the life cycle of amyloid plaques. Ann. Neurol. 1997;42:909\u2013918. doi: 10.1002/ana.410420613.", "ArticleIdList": ["10.1002/ana.410420613", "9403484"]}, {"Citation": "Darvesh S., Cash M.K., Reid G.A., Martin E., Mitnitski A., Geula C. Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2012;71:2\u201314. doi: 10.1097/NEN.0b013e31823cc7a6.", "ArticleIdList": ["10.1097/NEN.0b013e31823cc7a6", "PMC3246090", "22157615"]}, {"Citation": "Mizukami K., Akatsu H., Abrahamson E.E., Mi Z., Ikonomovic M.D. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer\u2019s disease. Neuropathology. 2016;36:135\u2013145. doi: 10.1111/neup.12241.", "ArticleIdList": ["10.1111/neup.12241", "PMC4761534", "26293308"]}, {"Citation": "Cash M.K., Rockwood K., Fisk J.D., Darvesh S. Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer\u2019s disease with the presenilin 1 mutation, Leu235Pro. Neurobiol. Aging. 2021;103:31\u201341. doi: 10.1016/j.neurobiolaging.2021.02.025.", "ArticleIdList": ["10.1016/j.neurobiolaging.2021.02.025", "33789210"]}, {"Citation": "Olivares D., Deshpande V.K., Shi Y., Lahiri D.K., Greig N.H., Rogers J.T., Huang X. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease. Curr. Alzheimer Res. 2012;9:746\u2013758. doi: 10.2174/156720512801322564.", "ArticleIdList": ["10.2174/156720512801322564", "PMC5002349", "21875407"]}, {"Citation": "Fong R.K., Johnson A., Gill S.S. Cholinesterase inhibitors: An example of geographic variation in prescribing patterns within a drug class. Int. J. Geriatr. Psychiatry. 2015;30:220\u2013222. doi: 10.1002/gps.4212.", "ArticleIdList": ["10.1002/gps.4212", "25639835"]}, {"Citation": "Atri A. Current and future treatments in Alzheimer\u2019s disease. Semin. Neurol. 2019;39:227\u2013240. doi: 10.1055/s-0039-1678581.", "ArticleIdList": ["10.1055/s-0039-1678581", "30925615"]}, {"Citation": "Ahmed H., Haider A., Ametamey S.M. N-Methyl-D-Aspartate (NMDA) receptor modulators: A patent review (2015-present) Expert Opin. Ther. Pat. 2020;30:743\u2013767. doi: 10.1080/13543776.2020.1811234.", "ArticleIdList": ["10.1080/13543776.2020.1811234", "32926646"]}, {"Citation": "Pohanka M. Inhibitors of cholinesterases in pharmacology: The Current Trends. Mini Rev. Med. Chem. 2020;20:1532\u20131542. doi: 10.2174/1389557519666191018170908.", "ArticleIdList": ["10.2174/1389557519666191018170908", "31656151"]}, {"Citation": "Przyby\u0142owska M., Dzierzbicka K., Kowalski S., Chmielewska K., Inkielewicz-Stepniak I. Therapeutic potential of multifunctional derivatives of cholinesterase inhibitors. Curr. Neuropharmacol. 2021;19:1323\u20131344. doi: 10.2174/1570159X19666201218103434.", "ArticleIdList": ["10.2174/1570159X19666201218103434", "PMC8719290", "33342413"]}, {"Citation": "Imbimbo B.P., Giardina G.A. \u03b3-Secretase inhibitors and modulators for the treatment of Alzheimer\u2019s disease: Disappointments and hopes. Curr. Top. Med. Chem. 2011;11:1555\u20131570. doi: 10.2174/156802611795860942.", "ArticleIdList": ["10.2174/156802611795860942", "21510832"]}, {"Citation": "Golde T.E., Koo E.H., Felsenstein K.M., Osborne B.A., Miele L. \u03b3-Secretase inhibitors and modulators. Biochim. Biophys. Acta. 2013;1828:2898\u20132907. doi: 10.1016/j.bbamem.2013.06.005.", "ArticleIdList": ["10.1016/j.bbamem.2013.06.005", "PMC3857966", "23791707"]}, {"Citation": "Moussa C.E. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer\u2019s disease. Expert. Opin. Investig. Drugs. 2017;26:1131\u20131136. doi: 10.1080/13543784.2017.1369527.", "ArticleIdList": ["10.1080/13543784.2017.1369527", "28817311"]}, {"Citation": "Moussa-Pacha N.M., Abdin S.M., Omar H.A., Alniss H., Al-Tel T.H. BACE1 inhibitors: Current status and future directions in treating Alzheimer\u2019s disease. Med. Res. Rev. 2020;40:339\u2013384. doi: 10.1002/med.21622.", "ArticleIdList": ["10.1002/med.21622", "31347728"]}, {"Citation": "Hur J.Y. \u03b3-Secretase in Alzheimer\u2019s disease. Exp. Mol. Med. 2022;54:433\u2013446. doi: 10.1038/s12276-022-00754-8.", "ArticleIdList": ["10.1038/s12276-022-00754-8", "PMC9076685", "35396575"]}, {"Citation": "Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., et al. Inflammation and Alzheimer\u2019s disease. Neurobiol. Aging. 2000;21:383\u2013421. doi: 10.1016/S0197-4580(00)00124-X.", "ArticleIdList": ["10.1016/S0197-4580(00)00124-X", "PMC3887148", "10858586"]}, {"Citation": "Chen Z., Zhong C. Oxidative stress in Alzheimer\u2019s disease. Neurosci. Bull. 2014;30:271\u2013281. doi: 10.1007/s12264-013-1423-y.", "ArticleIdList": ["10.1007/s12264-013-1423-y", "PMC5562667", "24664866"]}, {"Citation": "Newcombe E.A., Camats-Perna J., Silva M.L., Valmas N., Huat T.J., Medeiros R. Inflammation: The link between comorbidities, genetics, and Alzheimer\u2019s disease. J. Neuroinflammation. 2018;15:276. doi: 10.1186/s12974-018-1313-3.", "ArticleIdList": ["10.1186/s12974-018-1313-3", "PMC6154824", "30249283"]}, {"Citation": "Swerdlow R.H. Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 2018;62:1403\u20131416. doi: 10.3233/JAD-170585.", "ArticleIdList": ["10.3233/JAD-170585", "PMC5869994", "29036828"]}, {"Citation": "Huat T.J., Camats-Perna J., Newcombe E.A., Valmas N., Kitazawa M., Medeiros R. Metal toxicity links to Alzheimer\u2019s disease and neuroinflammation. J. Mol. Biol. 2019;431:1843\u20131868. doi: 10.1016/j.jmb.2019.01.018.", "ArticleIdList": ["10.1016/j.jmb.2019.01.018", "PMC6475603", "30664867"]}, {"Citation": "Birla H., Minocha T., Kumar G., Misra A., Singh S.K. Role of oxidative stress and metal toxicity in the progression of Alzheimer\u2019s disease. Curr. Neuropharmacol. 2020;18:552\u2013562. doi: 10.2174/1570159X18666200122122512.", "ArticleIdList": ["10.2174/1570159X18666200122122512", "PMC7457422", "31969104"]}, {"Citation": "Amidfar M., de Oliveira J., Kucharska E., Budni J., Kim Y.K. The role of CREB and BDNF in neurobiology and treatment of Alzheimer\u2019s disease. Life Sci. 2020;257:118020. doi: 10.1016/j.lfs.2020.118020.", "ArticleIdList": ["10.1016/j.lfs.2020.118020", "32603820"]}, {"Citation": "Hashemiaghdam A., Mroczek M. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer\u2019s disease. J. Neuroimmunol. 2020;341:577185. doi: 10.1016/j.jneuroim.2020.577185.", "ArticleIdList": ["10.1016/j.jneuroim.2020.577185", "32045774"]}, {"Citation": "Yoo S.M., Park J., Kim S.H., Jung Y.K. Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer\u2019s disease. BMB Rep. 2020;53:35\u201346. doi: 10.5483/BMBRep.2020.53.1.274.", "ArticleIdList": ["10.5483/BMBRep.2020.53.1.274", "PMC6999830", "31818363"]}, {"Citation": "Ionescu-Tucker A., Cotman C.W. Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease. Neurobiol. Aging. 2021;107:86\u201395. doi: 10.1016/j.neurobiolaging.2021.07.014.", "ArticleIdList": ["10.1016/j.neurobiolaging.2021.07.014", "34416493"]}, {"Citation": "Bhatia V., Sharma S. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer\u2019s disease. J. Neurol. Sci. 2021;421:117253. doi: 10.1016/j.jns.2020.117253.", "ArticleIdList": ["10.1016/j.jns.2020.117253", "33476985"]}, {"Citation": "Takata K., Ginhoux F., Shimohama S. Roles of microglia in Alzheimer\u2019s disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention. Biochem. Pharmacol. 2021;192:114754. doi: 10.1016/j.bcp.2021.114754.", "ArticleIdList": ["10.1016/j.bcp.2021.114754", "34480881"]}, {"Citation": "Peng Y., Chang X., Lang M. Iron homeostasis disorder and Alzheimer\u2019s disease. Int. J. Mol. Sci. 2021;22:12442. doi: 10.3390/ijms222212442.", "ArticleIdList": ["10.3390/ijms222212442", "PMC8622469", "34830326"]}, {"Citation": "Silvin A., Uderhardt S., Piot C., Da Mesquita S., Yang K., Geirsdottir L., Mulder K., Eyal D., Liu Z., Bridlance C., et al. Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration. Immunity. 2022;55:1448\u20131465.e6. doi: 10.1016/j.immuni.2022.07.004.", "ArticleIdList": ["10.1016/j.immuni.2022.07.004", "35931085"]}, {"Citation": "Tolar M., Abushakra S., Hey J.A., Porsteinsson A., Sabbagh M. Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer\u2019s disease with potential for near term approval. Alzheimer\u2019s Res. Ther. 2020;12:95. doi: 10.1186/s13195-020-00663-w.", "ArticleIdList": ["10.1186/s13195-020-00663-w", "PMC7424995", "32787971"]}, {"Citation": "Jeremic D., Jim\u00e9nez-D\u00edaz L., Navarro-L\u00f3pez J.D. Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: A systematic review. Ageing Res. Rev. 2021;72:101496. doi: 10.1016/j.arr.2021.101496.", "ArticleIdList": ["10.1016/j.arr.2021.101496", "34687956"]}, {"Citation": "Kuller L.H., Lopez O.L. ENGAGE and EMERGE: Truth and consequences? Alzheimer\u2019s Dement. 2021;17:692\u2013695. doi: 10.1002/alz.12286.", "ArticleIdList": ["10.1002/alz.12286", "PMC8248059", "33656288"]}, {"Citation": "Knopman D.S., Jones D.T., Greicius M.D. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimer\u2019s Dement. 2021;17:696\u2013701. doi: 10.1002/alz.12213.", "ArticleIdList": ["10.1002/alz.12213", "33135381"]}, {"Citation": "Orini S., Geroldi C., Zanetti O. The new therapy for Alzheimer\u2019s disease: From a hope for a few to a false hope? Aging Clin. Exp. Res. 2022;34:3151\u20133153. doi: 10.1007/s40520-022-02141-9.", "ArticleIdList": ["10.1007/s40520-022-02141-9", "35587336"]}, {"Citation": "Bardia A., Nisly N.L., Zimmerman M.B., Gryzlak B.M., Wallace R.B. Use of herbs among adults based on evidence-based indications: Findings from the National Health Interview Survey. Mayo Clin. Proc. 2007;82:561\u2013566. doi: 10.4065/82.5.561.", "ArticleIdList": ["10.4065/82.5.561", "PMC1964882", "17493422"]}, {"Citation": "Braun L., Cohen M. Herbs and Natural Supplements, Volume 2: An Evidence-Based Guide. Elsevier Health Sciences, Elsevier; Chatswood, Australia: 2005."}, {"Citation": "Moss M., Smith E., Milner M., McCready J. Acute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults. J. Psychopharmacol. 2018;32:1319\u20131329. doi: 10.1177/0269881118798339.", "ArticleIdList": ["10.1177/0269881118798339", "30318972"]}, {"Citation": "Gregory J., Vengalasetti Y.V., Bredesen D.E., Rao R.V. Neuroprotective herbs for the management of Alzheimer\u2019s disease. Biomolecules. 2021;11:543. doi: 10.3390/biom11040543.", "ArticleIdList": ["10.3390/biom11040543", "PMC8068256", "33917843"]}, {"Citation": "Yang G., Wang Y., Sun J., Zhang K., Liu J. Ginkgo biloba for mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled trials. Curr. Top. Med. Chem. 2016;16:520\u2013528. doi: 10.2174/1568026615666150813143520.", "ArticleIdList": ["10.2174/1568026615666150813143520", "26268332"]}, {"Citation": "Tian J., Liu Y., Chen K. Ginkgo biloba extract in vascular protection: Molecular mechanisms and clinical applications. Curr. Vasc. Pharmacol. 2017;15:532\u2013548. doi: 10.2174/1570161115666170713095545.", "ArticleIdList": ["10.2174/1570161115666170713095545", "28707602"]}, {"Citation": "Singh S.K., Srivastav S., Castellani R.J., Plascencia-Villa G., Perry G. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019;16:666\u2013674. doi: 10.1007/s13311-019-00767-8.", "ArticleIdList": ["10.1007/s13311-019-00767-8", "PMC6694352", "31376068"]}, {"Citation": "Vellas B., Coley N., Ousset P.-J., Berrut G., Dartigues J.-F., Dubois B., Grandjean H., Pasquier F., Piette F., Robert P., et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer\u2019s disease (GuidAge): A randomised placebo-controlled trial. Lancet Neurol. 2012;11:851\u2013859. doi: 10.1016/S1474-4422(12)70206-5.", "ArticleIdList": ["10.1016/S1474-4422(12)70206-5", "22959217"]}, {"Citation": "Patwardhan B. Ethnopharmacology and drug discovery. J. Ethnopharmacol. 2005;100:50\u201352. doi: 10.1016/j.jep.2005.06.006.", "ArticleIdList": ["10.1016/j.jep.2005.06.006", "16023811"]}, {"Citation": "Sen T., Samanta S.K. Medicinal plants, human health and biodiversity: A broad review. Adv. Biochem. Eng. Biotechnol. 2015;147:59\u2013110. doi: 10.1007/10_2014_273.", "ArticleIdList": ["10.1007/10_2014_273", "25001990"]}, {"Citation": "Leonti M., Stafford G., Cero M.D., Cabras S., Castellanos M.E., Casu L., Weckerle C. Reverse ethnopharmacology and drug discovery. J. Ethnopharmacol. 2017;198:417\u2013431. doi: 10.1016/j.jep.2016.12.044.", "ArticleIdList": ["10.1016/j.jep.2016.12.044", "28063920"]}, {"Citation": "Pirintsos S., Panagiotopoulos A., Bariotakis M., Daskalakis V., Lionis C., Sourvinos G., Karakasiliotis I., Kampa M., Castanas E. From traditional ethnopharmacology to modern natural drug discovery: A methodology discussion and specific examples. Molecules. 2022;27:4060. doi: 10.3390/molecules27134060.", "ArticleIdList": ["10.3390/molecules27134060", "PMC9268545", "35807306"]}, {"Citation": "Farnsworth N.R. Ethnopharmacology and drug development. Ciba. Found. Symp. 1994;185:42\u201351. doi: 10.1002/9780470514634.ch4.", "ArticleIdList": ["10.1002/9780470514634.ch4", "7736861"]}, {"Citation": "Casta\u00f1eda R., Natarajan S., Jeong S.Y., Hong B.N., Kang T.H. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery? J. Ethnopharmacol. 2019;231:409\u2013428. doi: 10.1016/j.jep.2018.11.016.", "ArticleIdList": ["10.1016/j.jep.2018.11.016", "30439402"]}, {"Citation": "Leonti M. The relevance of quantitative ethnobotanical indices for ethnopharmacology and ethnobotany. J. Ethnopharmacol. 2022;288:115008. doi: 10.1016/j.jep.2022.115008.", "ArticleIdList": ["10.1016/j.jep.2022.115008", "35066067"]}, {"Citation": "Nasim N., Sandeep I.S., Mohanty S. Plant-derived natural products for drug discovery: Current approaches and prospects. Nucleus. 2022;18:399\u2013411. doi: 10.1007/s13237-022-00405-3.", "ArticleIdList": ["10.1007/s13237-022-00405-3", "PMC9579558", "36276225"]}, {"Citation": "Perry N., Court G., Bidet N., Court J., Perry E. European herbs with cholinergic activities: Potential in dementia therapy. Int. J. Geriatr. Psychiatry. 1996;11:1063\u20131069. doi: 10.1002/(SICI)1099-1166(199612)11:12<1063::AID-GPS532>3.0.CO;2-1.", "ArticleIdList": ["10.1002/(SICI)1099-1166(199612)11:12<1063::AID-GPS532>3.0.CO;2-1"]}, {"Citation": "Kuang P., Tao Y., Tian Y. Radix Salviae miltiorrhizae treatment results in decreased lipid peroxidation in reperfusion injury. J. Tradit. Chin. Med. 1996;16:138\u2013142.", "ArticleIdList": ["9389144"]}, {"Citation": "Kamatou G.P., Makunga N.P., Ramogola W.P., Viljoen A.M. South African Salvia species: A review of biological activities and phytochemistry. J. Ethnopharmacol. 2008;119:664\u2013672. doi: 10.1016/j.jep.2008.06.030.", "ArticleIdList": ["10.1016/j.jep.2008.06.030", "18640254"]}, {"Citation": "Xu S.S., Gao Z.X., Weng Z., Du Z.M., Xu W.A., Yang J.S., Zhang M.L., Tong Z.H., Fang Y.S., Chai X.S. Efficacy of tablet huperzine A on memory, cognition, and behavior in Alzheimer\u2019s disease. Zhongguo Yao Li Xue Bao. 1995;16:391\u2013395.", "ArticleIdList": ["8701750"]}, {"Citation": "Zhang R., Tang X., Han Y., Sang G.W., Zhang Y.D., Ma Y.X., Zhang C.L., Yang R.M. Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao. 1991;12:250\u2013252.", "ArticleIdList": ["1781288"]}, {"Citation": "Bai D.L., Tang X.C., He X.C. Huperzine A, a potential therapeutic agent for treatment of Alzheimer\u2019s disease. Curr. Med. Chem. 2000;7:355\u2013374. doi: 10.2174/0929867003375281.", "ArticleIdList": ["10.2174/0929867003375281", "10637369"]}, {"Citation": "Yang G., Wang Y., Tian J., Liu J.P. Huperzine A for Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized clinical trials. PLoS ONE. 2013;23:e74916. doi: 10.1371/journal.pone.0074916.", "ArticleIdList": ["10.1371/journal.pone.0074916", "PMC3781107", "24086396"]}, {"Citation": "Villegas C., Perez R., Petiz L.L., Glaser T., Ulrich H., Paz C. Ginkgolides and huperzine A for complementary treatment of Alzheimer\u2019s disease. IUBMB Life. 2022;74:763\u2013779. doi: 10.1002/iub.2613.", "ArticleIdList": ["10.1002/iub.2613", "35384262"]}, {"Citation": "Perry N.S.L., Houghton P.J., Sampson J., Theobald A.E., Hart S., Lis-Balchin M., Hoult J.R.S., Evans P., Jenner P., Milligan S., et al. In vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer\u2019s disease. J. Pharm. Pharmacol. 2001;53:1347\u20131356. doi: 10.1211/0022357011777846.", "ArticleIdList": ["10.1211/0022357011777846", "11697542"]}, {"Citation": "Perry N.S.L., Houghton P.J., Jenner P., Keith A., Perry E.K. Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. Phytomedicine. 2002;9:48\u201351. doi: 10.1078/0944-7113-00082.", "ArticleIdList": ["10.1078/0944-7113-00082", "11926204"]}, {"Citation": "Tildesley N.T., Kennedy D.O., Perry E.K., Ballard C.G., Savelev S.A.W.K., Wesnes K.A., Scholey A.B. Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharm. Biochem. Behavior. 2003;75:669\u2013674. doi: 10.1016/S0091-3057(03)00122-9.", "ArticleIdList": ["10.1016/S0091-3057(03)00122-9", "12895685"]}, {"Citation": "Ren Y., Houghton P.J., Hider R.C., Howes M.R. Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med. 2004;70:201\u2013204. doi: 10.1055/s-2004-815535.", "ArticleIdList": ["10.1055/s-2004-815535", "15114495"]}, {"Citation": "Imanshahidi M., Hosseinzadeh H. The pharmacological effects of Salvia species on the central nervous system. Phytother. Res. 2006;20:427\u2013437. doi: 10.1002/ptr.1898.", "ArticleIdList": ["10.1002/ptr.1898", "16619340"]}, {"Citation": "Lin H.Q., Ho M.T., Lau L.S., Wong K.K., Shaw P.C., Wan D.C.C. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer\u2019s disease. Chem. Biol. Inter. 2008;175:352\u2013354. doi: 10.1016/j.cbi.2008.05.030.", "ArticleIdList": ["10.1016/j.cbi.2008.05.030", "18573242"]}, {"Citation": "Perry E.K., Pickering A.T., Wang W.W., Houghton P., Perry N.S. Medicinal plants and Alzheimer\u2019s disease: Integrating ethnobotanical and contemporary scientific evidence. J. Altern. Complement Med. 1998;4:419\u2013428. doi: 10.1089/acm.1998.4.419.", "ArticleIdList": ["10.1089/acm.1998.4.419", "9884179"]}, {"Citation": "Perry E.K., Pikering A.T., Wang W.W., Houghton P.J., Perry N.S. Medicinal plants and Alzheimer\u2019s disease: From ethnobotany to phytotherapy. J. Pharm. Pharmacol. 1999;51:527\u2013534. doi: 10.1211/0022357991772808.", "ArticleIdList": ["10.1211/0022357991772808", "10411211"]}, {"Citation": "Perry E., Howes M.J. Medicinal plants and dementia therapy: Herbal hopes for brain aging. CNS Neurosci. Ther. 2011;17:683\u2013698. doi: 10.1111/j.1755-5949.2010.00202.x.", "ArticleIdList": ["10.1111/j.1755-5949.2010.00202.x", "PMC6493900", "22070157"]}, {"Citation": "Wake G., Court J., Pikering A., Lewis R., Wilkins R., Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J. Ethnopharmacol. 2000;69:105\u2013114. doi: 10.1016/S0378-8741(99)00113-0.", "ArticleIdList": ["10.1016/S0378-8741(99)00113-0", "10687867"]}, {"Citation": "Kennedy D.O., Scholey A.B., Tildesley N.T.J., Perry E.K., Wesnes K.A. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) Pharmacol. Biochem. Behav. 2002;72:953\u2013964. doi: 10.1016/S0091-3057(02)00777-3.", "ArticleIdList": ["10.1016/S0091-3057(02)00777-3", "12062586"]}, {"Citation": "Perry N.S., Bollen C., Perry E.K., Ballard C. Salvia for dementia therapy: Review of pharmacological activity and pilot tolerability clinical trial. Pharmacol. Biochem. Behav. 2003;75:651\u2013659. doi: 10.1016/S0091-3057(03)00108-4.", "ArticleIdList": ["10.1016/S0091-3057(03)00108-4", "12895683"]}, {"Citation": "Miroddi M., Navarra M., Quattropani M., Calapai C., Gangemi F., Calapai S.G. Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer\u2019s disease. CNS Neurosci. Ther. 2014;20:485\u2013495. doi: 10.1111/cns.12270.", "ArticleIdList": ["10.1111/cns.12270", "PMC6493168", "24836739"]}, {"Citation": "Lopresti A.L. Salvia (Sage): A review of its potential cognitive-enhancing and protective effects. Drugs R&D. 2017;17:53\u201364. doi: 10.1007/s40268-016-0157-5.", "ArticleIdList": ["10.1007/s40268-016-0157-5", "PMC5318325", "27888449"]}, {"Citation": "Ghorbani A., Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med. 2014;7:433\u2013440. doi: 10.1016/j.jtcme.2016.12.014.", "ArticleIdList": ["10.1016/j.jtcme.2016.12.014", "PMC5634728", "29034191"]}, {"Citation": "Kennedy D., Pace S., Haskell C.F., Okello E.J., Milne A., Scholey A. Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology. 2006;31:845\u2013852. doi: 10.1038/sj.npp.1300907.", "ArticleIdList": ["10.1038/sj.npp.1300907", "16205785"]}, {"Citation": "Akhondzadeh S., Noroozian M., Mohammadi M., Ohadinia S., Jamshidi A.H., Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: A double blind, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 2003;28:53\u201359. doi: 10.1046/j.1365-2710.2003.00463.x.", "ArticleIdList": ["10.1046/j.1365-2710.2003.00463.x", "12605619"]}, {"Citation": "Garg V., Dhar V.J., Sharma A., Dutt R. Facts about standardization of herbal medicine: A review. Chin. J. Integr. Med. 2012;10:1077\u20131083. doi: 10.3736/jcim20121002.", "ArticleIdList": ["10.3736/jcim20121002", "23073189"]}, {"Citation": "Zhang J., Wider B., Shang H., Li X., Ernst E. Quality of herbal medicines: Challenges and solutions. Complement. Ther. Med. 2012;20:100\u2013106. doi: 10.1016/j.ctim.2011.09.004.", "ArticleIdList": ["10.1016/j.ctim.2011.09.004", "22305255"]}, {"Citation": "L\u00e4nger R., St\u00f6ger E., Kubelka W., Helliwell K. Quality standards for herbal drugs and herbal drug preparations\u2014Appropriate or improvements necessary? Planta Med. 2018;84:350\u2013360. doi: 10.1055/s-0043-118534.", "ArticleIdList": ["10.1055/s-0043-118534", "28850958"]}, {"Citation": "Li Y., Shen Y., Yao C.L., Guo D.A. Quality assessment of herbal medicines based on chemical fingerprints combined with chemometrics approach: A review. J. Pharm. Biomed. Anal. 2020;185:113215. doi: 10.1016/j.jpba.2020.113215.", "ArticleIdList": ["10.1016/j.jpba.2020.113215", "32199327"]}, {"Citation": "Scholey A., Tildesley N.T.J., Ballard C., Wesnes K., Tasker A., Perry E.K., Kennedy D. An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology. 2008;198:127\u2013139. doi: 10.1007/s00213-008-1101-3.", "ArticleIdList": ["10.1007/s00213-008-1101-3", "18350281"]}, {"Citation": "Laybourne G., Moss M., Wesnes K., Scott S.D. Effects of acute oral administration of rosemary and peppermint on cognition and mood in healthy adults. J. Psychopharmacol. 2003;17:A62."}, {"Citation": "Tildesley N.T.J., Kennedy E.K., Perry C.G., Ballard C.G., Wesnes K.A., Scholey A.B. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol. Behav. 2005;83:699\u2013709. doi: 10.1016/j.physbeh.2004.09.010.", "ArticleIdList": ["10.1016/j.physbeh.2004.09.010", "15639154"]}, {"Citation": "Moss L., Rouse M., Wesnes K.A., Moss M. Differential effects of the aromas of Salvia species on memory and moody. Hum. Psychopharmacol. Clin. Exp. 2010;25:388\u2013396. doi: 10.1002/hup.1129.", "ArticleIdList": ["10.1002/hup.1129", "20589925"]}, {"Citation": "Kennedy D.O., Dodd F., Robertson B.C., Okello E.J., Reay J., Scholey A., Haskell C.F. Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. J. Psychopharmacol. 2011;25:1088\u20131100. doi: 10.1177/0269881110385594.", "ArticleIdList": ["10.1177/0269881110385594", "20937617"]}, {"Citation": "Wightman E.L., Jackson P.A., Spittlehouse B., Heffernan T., Guillemet D., Kennedy D.O. The acute and chronic cognitive effects of a sage extract: A randomized, placebo-controlled study in healthy humans. Nutrients. 2021;13:218. doi: 10.3390/nu13010218.", "ArticleIdList": ["10.3390/nu13010218", "PMC7828691", "33466627"]}, {"Citation": "Kennedy D.O., Wake G., Savelev S., Tildesley N.T.J., Perry E.K., Wesnes K.A., Scholey A.B. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003;28:1871\u20131881. doi: 10.1038/sj.npp.1300230.", "ArticleIdList": ["10.1038/sj.npp.1300230", "12888775"]}, {"Citation": "Pengelly A., Snow J., Mills S.Y., Scholey A., Wesnes K., Butler L.R. Short-term study on the effects of rosemary on cognitive function in an elderly population. J. Med. Food. 2012;15:10\u201317. doi: 10.1089/jmf.2011.0005.", "ArticleIdList": ["10.1089/jmf.2011.0005", "21877951"]}, {"Citation": "Wang N.S., Liang M.R., Liu O.D. An experimental study on the effects of borneol as adjuvant drug and messenger drug. J. Tradit. Chin. Med. 1994;35:46\u201347."}, {"Citation": "Perry N.S.L., Menzies R., Hodgson F., Wedgewood P., Howes M.R., Brooker H.J., Wesnes K.A., Perry E.K. A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age. Phytomedicine. 2018;15:42\u201348. doi: 10.1016/j.phymed.2017.08.015.", "ArticleIdList": ["10.1016/j.phymed.2017.08.015", "29433682"]}, {"Citation": "Tejeda H.A., Shippenburg T.S., Henriksson R. The dynorphin/\u03ba-opioid receptor system and its role in psychiatric disorders. Cell. Mol. Life Sci. 2012;69:857\u2013896. doi: 10.1007/s00018-011-0844-x.", "ArticleIdList": ["10.1007/s00018-011-0844-x", "PMC11114766", "22002579"]}, {"Citation": "Johnson M.W., MacLean K.A., Reissig C.J., Prisinzano T.E., Griffiths R.R. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum. Drug Alcohol Depend. 2011;115:150\u2013155. doi: 10.1016/j.drugalcdep.2010.11.005.", "ArticleIdList": ["10.1016/j.drugalcdep.2010.11.005", "PMC3089685", "21131142"]}, {"Citation": "Griffiths R.R., Johnson M.W., Richards W.A., Richards B.R., McCann U.D., Jesse R. Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology. 2011;218:649\u2013665. doi: 10.1007/s00213-011-2358-5.", "ArticleIdList": ["10.1007/s00213-011-2358-5", "PMC3308357", "21674151"]}, {"Citation": "Karam A., Said A., Assaad C., Hallit S., Haddad G., Hachem D., Kazour F. Abuse and effects of Salvia divinorum in a sample of patients hospitalized for substance dependence. Community Ment. Health J. 2019;55:702\u2013708. doi: 10.1007/s10597-018-0347-4.", "ArticleIdList": ["10.1007/s10597-018-0347-4", "30374761"]}, {"Citation": "Orhan I., Aslan S., Kartal M., Sener B., Baser K.H.C. Inhibitory effect of Turkish Rosmarinus officinalis L. on acetylcholinesterase and butyrylcholinesterase enzymes. Food Chem. 2008;108:663\u2013668. doi: 10.1016/j.foodchem.2007.11.023.", "ArticleIdList": ["10.1016/j.foodchem.2007.11.023", "26059146"]}, {"Citation": "Moss M., Oliver L. Plasma 1,8-cineole correlates with cognitive performance following exposure to rosemary essential oil aroma. Ther. Adv. Psychopharmacol. 2012;2:103\u2013113. doi: 10.1177/2045125312436573.", "ArticleIdList": ["10.1177/2045125312436573", "PMC3736918", "23983963"]}, {"Citation": "Boyle R.R., McLean S., Brandon S., Wiggins N. Rapid absorption of dietary 1,8-cineole results in critical blood concentration of cineole and immediate cessation of eating in the common brushtail possum (Trichosurus vulpecula) J. Chem. Ecol. 2005;31:2775\u20132790. doi: 10.1007/s10886-005-8393-0.", "ArticleIdList": ["10.1007/s10886-005-8393-0", "16365704"]}, {"Citation": "Porres-Mart\u00ednez M., Gonz\u00e1lez-Burgos E., Carretero M.E., G\u00f3mez-Serranillos M.P. Major selected monoterpenes alpha-pinene and 1,8-cineole found in Salvia lavandulifolia (Spanish sage) essential oil as regulators of cellular redox balance. Pharm. Biol. 2014;53:921\u2013929. doi: 10.3109/13880209.2014.950672.", "ArticleIdList": ["10.3109/13880209.2014.950672", "25474583"]}, {"Citation": "Kammoun El Euch S., Hassine D.B., Cazaux S., Bouzouita N., Bouajila J. Salvia officinalis essential oil: Chemical analysis and evaluation of antienzymatic and antioxidant bioactivities. South Afr. J. Bot. 2019;120:253\u2013260. doi: 10.1016/j.sajb.2018.07.010.", "ArticleIdList": ["10.1016/j.sajb.2018.07.010"]}, {"Citation": "Dinel A.L., Lucas C., Guillemet D., Lay\u00e9 S., Pallet V., Joffre C. Chronic supplementation with a mix of Salvia officinalis and Salvia lavandulaefolia improves morris water maze learning in normal adult C57Bl/6J mice. Nutrients. 2020;12:1777. doi: 10.3390/nu12061777.", "ArticleIdList": ["10.3390/nu12061777", "PMC7353372", "32549250"]}, {"Citation": "Yamauchi T. Neuronal Ca2+/Calmodulin-Dependent Protein Kinase II\u2014Discovery, progress in a quarter of a century, and perspective: Implication for learning and memory. Biol. Pharm. Bull. 2005;28:1342\u20131354. doi: 10.1248/bpb.28.1342.", "ArticleIdList": ["10.1248/bpb.28.1342", "16079472"]}, {"Citation": "Fraize N., Hamieh A.M., Joseph M.A., Touret M., Parmentier R., Salin P.A., Malleret G. Differential changes in hippocampal CaMKII and GluA1 activity after memory training involving different levels of adaptive forgetting. Learn. Mem. 2017;24:86\u201394. doi: 10.1101/lm.043505.116.", "ArticleIdList": ["10.1101/lm.043505.116", "PMC5238719", "28096498"]}, {"Citation": "Alzheimer\u2019s Association 2015 Alzheimer Facts and Figures. Alzheimers Dement. 2015;11:332\u2013384. doi: 10.1016/j.jalz.2015.02.003.", "ArticleIdList": ["10.1016/j.jalz.2015.02.003", "25984581"]}, {"Citation": "Canevelli M., Lucchini F., Quarata F., Bruno G., Cesari M. Nutrition and dementia: Evidence for preventive approaches. Nutrients. 2016;8:144. doi: 10.3390/nu8030144.", "ArticleIdList": ["10.3390/nu8030144", "PMC4808873", "26959055"]}, {"Citation": "Hamaguchi T., Ono K., Murase A., Yamada M. Phenolic compounds prevent Alzheimer\u2019s pathology through different effects on the amyloid-\u03b2 aggregation pathway. Am. J. Pathol. 2009;175:2557\u20132565. doi: 10.2353/ajpath.2009.090417.", "ArticleIdList": ["10.2353/ajpath.2009.090417", "PMC2789642", "19893028"]}, {"Citation": "Kayashima T., Matsubara K. Antiangiogenic effect of carnosic acid and carnosol, neuroprotective compounds in rosemary leaves. Biosci. Biotechnol. Biochem. 2012;76:115\u2013119. doi: 10.1271/bbb.110584.", "ArticleIdList": ["10.1271/bbb.110584", "22232247"]}, {"Citation": "Sasaki K., El Omri A., Kondo S., Han J., Isoda H. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav. Brain Res. 2013;238:86\u201394. doi: 10.1016/j.bbr.2012.10.010.", "ArticleIdList": ["10.1016/j.bbr.2012.10.010", "23085339"]}, {"Citation": "Iversen T., Fiirgaard K.M., Schriver P., Rasmussen O., Andreasen F. The effect of NaO Li Su on memory functions and blood chemistry in elderly people. J. Ethnopharmacol. 1997;56:109\u2013116. doi: 10.1016/S0378-8741(97)01513-4.", "ArticleIdList": ["10.1016/S0378-8741(97)01513-4", "9174971"]}, {"Citation": "Li L.X., Ru L.Q. Influence of tanshinone on learning and memory impairment induced by amyloid\u03b2-peptide1-40 in rats. Chin. J. Gerontol. 2003;23:294\u2013297."}, {"Citation": "Jiang P., Chen M., Lv J., Chen C., Jiao B.H. Effect of tanshinone II A on MMP-2 and iNOS expression and free radical release in hippocampus of rat Alzheimer\u2019s disease mode. Acad. J. Second Military Med. Univ. 2010;31:380\u2013384. doi: 10.3724/SP.J.1008.2010.00380.", "ArticleIdList": ["10.3724/SP.J.1008.2010.00380"]}, {"Citation": "Zhu Y.L., Yang W.Q. Effects of compound tablet of red sage root on the expression of VEGF in brain of rat during chronic cerebral ischemia. Chin. J. Practical. Nerv. Dis. 2007;10:26\u201327."}, {"Citation": "Tian J., Shi J., Wei M., Qin R., Ni J., Zhang X., Li T., Wang Y. The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: A study protocol for a randomized controlled trial. Trials. 2016;17:281. doi: 10.1186/s13063-016-1410-5.", "ArticleIdList": ["10.1186/s13063-016-1410-5", "PMC4897894", "27266867"]}, {"Citation": "Perron B.E., Ahmedani B.K., Vaughn M.G., Glass J.E., Abdon A., Wu L.T. Use of Salvia divinorum in a nationally representative sample. Am. J. Drug Alcohol Abus. 2012;38:108\u2013113. doi: 10.3109/00952990.2011.600397.", "ArticleIdList": ["10.3109/00952990.2011.600397", "PMC3408869", "21834614"]}, {"Citation": "Cunningham C.W., Rothman R.B., Prisinzano T.E. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacol. Rev. 2011;63:316\u2013347. doi: 10.1124/pr.110.003244.", "ArticleIdList": ["10.1124/pr.110.003244", "PMC3082450", "21444610"]}, {"Citation": "Kivell B., Prisinzano T.E. Kappa opioids and the modulation of pain. Psychopharmacology. 2010;210:109\u2013119. doi: 10.1007/s00213-010-1819-6.", "ArticleIdList": ["10.1007/s00213-010-1819-6", "20372880"]}, {"Citation": "Addy P.H. Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology. 2012;220:195\u2013204. doi: 10.1007/s00213-011-2470-6.", "ArticleIdList": ["10.1007/s00213-011-2470-6", "21901316"]}, {"Citation": "Ranganathan M., Schnakenburg A., Skosnik P.D., Cohen B.M., Pittman B., Sewell R.A., D\u2019Souza D.C. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the \u03ba-opioid agonist salvinorin A in humans. Biol. Psychiatry. 2012;72:871\u2013879. doi: 10.1016/j.biopsych.2012.06.012.", "ArticleIdList": ["10.1016/j.biopsych.2012.06.012", "PMC3638802", "22817868"]}, {"Citation": "Mendelson J.E., Coyle J.R., Lopez J.C., Baggott M.J., Flower K., Everhart E.T., Munro T.A., Galloway G.P., Cohen B.M. Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: A placebo-controlled trial. Psychopharmacology. 2011;214:933\u2013939. doi: 10.1007/s00213-010-2103-5.", "ArticleIdList": ["10.1007/s00213-010-2103-5", "PMC3063546", "21140258"]}, {"Citation": "Albertson D.N., Grubbs L.E. Subjective effects of Salvia divinorum: LSD- or marijuana-like. J. Psychoact. Drugs. 2009;41:213\u2013217. doi: 10.1080/02791072.2009.10400531.", "ArticleIdList": ["10.1080/02791072.2009.10400531", "19999674"]}, {"Citation": "Baggott M.J., Erowid E., Erowid F., Galloway G.P., Mendelson J. Use patterns and self-reported effects of Salvia divinorum: An internet-based survey. Drug Alcohol Depend. 2010;111:250\u2013256. doi: 10.1016/j.drugalcdep.2010.05.003.", "ArticleIdList": ["10.1016/j.drugalcdep.2010.05.003", "20627425"]}, {"Citation": "Kelly B.C. Legally tripping: A qualitative profile of Salvia divinorum use among young adults. J. Psychoact. Drugs. 2011;43:46\u201354. doi: 10.1080/02791072.2011.566500.", "ArticleIdList": ["10.1080/02791072.2011.566500", "21615007"]}, {"Citation": "Sumnall H.R., Measham F., Brandt S.D., Cole J.C. Salvia divinorum use and phenomenology: Results from an online survey. J. Psychopharmacol. 2011;25:1496\u20131507. doi: 10.1177/0269881110385596.", "ArticleIdList": ["10.1177/0269881110385596", "20937616"]}, {"Citation": "MacLean K.A., Johnson M.W., Reissig C.J., Prisinzano T.E., Griffiths R.R. Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic, and memory effects. Psychopharmacology. 2013;226:381\u2013392. doi: 10.1007/s00213-012-2912-9.", "ArticleIdList": ["10.1007/s00213-012-2912-9", "PMC3581702", "23135605"]}, {"Citation": "Jackson P.A., Wightman E.L., Veasey R., Forster J., Khan J., Saunders C., Mitchell S., Haskell-Ramsay C.F., Kennedy D.O. A randomized, crossover study of the acute cognitive and cerebral blood flow effects of phenolic, nitrate and botanical beverages in young, healthy humans. Nutrients. 2020;12:2254. doi: 10.3390/nu12082254.", "ArticleIdList": ["10.3390/nu12082254", "PMC7468953", "32731478"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "11", "Day": "21"}, {"Year": "2022", "Month": "12", "Day": "23"}, {"Year": "2023", "Month": "1", "Day": "9"}, {"Year": "2023", "Month": "6", "Day": "1", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "1", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "1", "Hour": "1", "Minute": "1"}, {"Year": "2023", "Month": "1", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["37259321", "PMC9966473", "10.3390/ph16020171", "ph16020171"]}}], "PubmedBookArticle": []}